The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tessarz, A. S.
Right arrow Articles by Cerwenka, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tessarz, A. S.
Right arrow Articles by Cerwenka, A.
The Journal of Immunology, 2007, 178: 1991-1999.
Copyright © 2007 by The American Association of Immunologists, Inc.

Non-T Cell Activation Linker (NTAL) Negatively Regulates TREM-1/DAP12-Induced Inflammatory Cytokine Production in Myeloid Cells1

Anja S. Tessarz*, Sandra Weiler*, Kai Zanzinger*, Pavla Angelisová{dagger}, Václav Horejsí{dagger} and Adelheid Cerwenka2,*

* German Cancer Research Center (DKFZ), Division of Innate Immunity, Heidelberg, Germany, Europe; and {dagger} Academy of Sciences of the Czech Republic, Institute of Molecular Genetics, Prague, Czech Republic, Europe

The engagement of triggering receptor expressed on myeloid cells 1 (TREM-1) on macrophages and neutrophils leads to TNF-{alpha} and IL-8 production and enhances inflammatory responses to microbial products. For signal transduction, TREM-1 couples to the ITAM-containing adapter DNAX activation protein of 12 kDa (DAP12). In general, ITAM-mediated signals lead to cell activation, although DAP12 was recently implicated in inhibitory signaling in mouse macrophages and dendritic cells. To date, signals downstream of the TREM-1 and DAP12 complex in myeloid cells are poorly defined. By analyzing receptor-induced tyrosine phosphorylation patterns, we discovered that the ligation of TREM-1 leads to tyrosine phosphorylation of the non-T cell activation linker (NTAL; also called linker of activation in B cells or LAB) in a myelomonocytic cell line and primary human granulocytes. Using RNA interference to decrease the expression levels of NTAL, we demonstrate that in NTAL knockdown cell lines the phosphorylation of ERK1/2 is enhanced. In addition, low levels of NTAL are correlated with decreased and delayed mobilization of Ca2+ after TREM-1 triggering. Most importantly, we demonstrate that NTAL acts as a negative regulator of TNF-{alpha} and IL-8 production after stimulation via TREM-1. Our results show that activation signals delivered via DAP12 can be counterbalanced by the adaptor NTAL, identifying NTAL as gatekeeper of TREM-1/DAP12-induced signaling in myeloid cells.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Marie Curie Excellence Grant 002739 (to A.C.).

2 Address correspondence and reprint requests to Dr. Adelheid Cerwenka, German Cancer Research Center (DKFZ/D080), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. E-mail address: a.cerwenka{at}dkfz.de

3 Abbreviations used in this paper: DAP12, DNAX activation protein of 12 kDa; DN, dominant negative; Grb2, growth factor receptor-bound protein 2; LAT, linker of activation in T cells; LM, laurylmaltoside; LNGFR, low affinity nerve growth factor receptor; NTAL, non-T cell activation linker; N4, NTAL-4; N5, NTAL-5; PLC-{gamma}, phospholipase C-{gamma}; pY, phosphotyrosine; SBP, streptavidin binding peptide; shRNA, short hairpin RNA; siRNA, small interfering RNA; S6H, streptavidin binding peptide-6xHis; TREM-1, triggering receptor expressed on myeloid cells; U937-TD, U937 cells expressing TREM-1/DAP12; VC, empty vector control.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.